Development of anticonvulsant osteomalacia in epileptic patients on phenytoin treatment.
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001842:Bone and Bones / Q000378:metabolism; D002118:Calcium / Q000097:blood; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008903:Minerals / Q000378:metabolism; D010018:Osteomalacia / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D010672:Phenytoin / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors; D014807:Vitamin D / Q000627:therapeutic use
D008903:Minerals; D014807:Vitamin D; D010672:Phenytoin; D000469:Alkaline Phosphatase; D002118:Calcium